Abstract:[Background] Marine-derived natural products have become an important source of small molecule drugs in recent years. Genomic analysis showed that Streptomyces sp. B9173 contains a variety of biosynthetic gene clusters of natural products, with the potential to generate multiple new compounds. [Objective] The objective of this paper is to find new compounds with novel structures or unique biological activities from the strain B9173. [Methods] With the method combined with HPLC and LC-MS, we excluded the known compounds produced by B9173 and identified three unknown compounds as isolation targets. The secondary metabolites were isolated and purified using normal or reverse phase column chromatography, gel column chromatography and high performance liquid chromatography (HPLC) . The structures of the compounds were elucidated by using mass spectroscopy (MS) and nuclear magnetic resonance (NMR) . [Results] Three compounds were purified and identified as tryptanthrin, meisoindigo, and N, N-dimethylisoindigo. All three compounds belong to the 2-oxindole alkaloids. Tryptanthrin has diverse biological activity, including antibacterial activity, anti-inflammatory activity, anti-tumor activity. Tryptanthrin is a potential drug lead and it is the first time to be isolated from bacteria. Meisoindigo is a drug used for clinical treatment of chronic myelogenous leukemia in China. It was isolated for the first time in a microbial fermentation broth. Based on the metabolic background of B9173, we speculated the biosynthetic pathways of three compounds. [Conclusion] Three 2-oxindole alkaloids were purified and structurally elucidated based on their UV-vis spectra and MS data. This study enriches the types of microbially active natural products. The proposed biosynthetic pathways will lay the foundation for further research on the biosynthetic mechanisms of tryptanthrin and meisoindigo. Subsequently biosynthetic pathways for this class of compounds can be reconstructed using synthetic biology techniques, which will provide more convenient and low-cost biosynthesis method for tryptanthrin and meisoindigo.

Production and Identification of Inthomycin B Produced by a Deep-Sea Sediment-Derived Streptomyces sp. YB104 Based on Cultivation-Dependent Approach

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Exploration of Diverse Secondary Metabolites From Streptomyces sp. YINM00001, Using Genome Mining and One Strain Many Compounds Approach

Identification of the Streptothricin and Tunicamycin Biosynthetic Gene Clusters by Genome Mining in Streptomyces Sp. Strain Fd1-Xmd

Chromatography-bioluminescence coupling reveals surprising bioactivity of inthomycin A

2-Oxindole Alkaloids Produced by Marine-Derived Streptomyces Sp. B9173

Integrative Genomics and Bioactivity-Guided Isolation of Novel Antimicrobial Compounds from Streptomyces sp. KN37 in Agricultural Applications

Secondary Metabolites and Biosynthetic Gene Clusters Analysis of Deep-Sea Hydrothermal Vent-Derived Streptomyces sp. SCSIO ZS0520

Isolation and Identification of Newly Isolated Antagonistic Streptomyces Sp Strain Ap19-2 Producing Chromomycins

Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.

Antibiofilm Metabolites from Marine-derived Streptomyces sp. ZS-A31

Characterization and Biosynthetic Regulation of Isoflavone Genistein in Deep-Sea Actinomycetes Microbacterium sp. B1075

Genome guided investigation of antibiotics producing actinomycetales strain isolated from a Macau mangrove ecosystem

Genome-Directed Discovery of Tetrahydroisoquinolines from Deep-Sea Derived Streptomyces Niveus SCSIO 3406.

Genome-guided and mass spectrometry investigation of natural products produced by a potential new actinobacterial strain isolated from a mangrove ecosystem in Futian, Shenzhen, China

Stress-driven discovery of a cryptic antibiotic produced by Streptomyces sp. WU20 from Kueishantao hydrothermal vent with an integrated metabolomics strategy

New natural products identified by combined genomics-metabolomics profiling of marine Streptomyces sp. MP131-18

Characterization of inthomycin biosynthetic gene cluster revealing new insights into carboxamide formation

Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments

Discovery, Biosynthesis, and Heterologous Production of Streptoseomycin, an Anti-Microaerophilic Bacteria Macrodilactone